Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Liron Walsh"'
Autor:
Debbie S. Gipson, Maisha Pal, Hailey Desmond, Charles Anderson, Liron Walsh, Howard Trachtman, Susan F. Massengill, Patrick Gipson, Panduranga S. Rao, Joshua Thurman, Jeffrey Kopp, Elaine Kamil, Jennifer Lamothe, Laura H Mariani, Paula LaFleur, Suzanne Vento, Michelle O’Shaughnessy, Youssef M.K. Farag, Christine Simon, Noelle E. Carlozzi
Publikováno v:
Glomerular Diseases (2023)
Introduction: Edema is a common manifestation of proteinuric kidney diseases but there is no consensus approach for reliably evaluating edema. The objective of this study was to develop an edema clinician-reported outcome measure for use in patients
Externí odkaz:
https://doaj.org/article/087287d5e24644b286231e19975d9394
Autor:
Noelle E. Carlozzi, Susan F. Massengill, Howard Trachtman, Liron Walsh, Neena Singhal, Joseph M. LaVigne, Jennifer A. Miner, Hailey E. Desmond, Christian Lynam, Debbie S. Gipson
Publikováno v:
Kidney Medicine, Vol 3, Iss 4, Pp 484-497.e1 (2021)
Rationale & Objective: Assessment of how patients feel and function is needed for clinical care and research for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). The objective of this study was to develop a patient-reported
Externí odkaz:
https://doaj.org/article/a3fd02fcb9ac4f85bf35c2c474d40540
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
Autor:
Barry J. Byrne, Tarekegn Geberhiwot, Bruce A. Barshop, Richard Barohn, Derralynn Hughes, Drago Bratkovic, Claude Desnuelle, Pascal Laforet, Eugen Mengel, Mark Roberts, Peter Haroldsen, Kristin Reilley, Kala Jayaram, Ke Yang, Liron Walsh, on behalf of the POM-001/002 Investigators
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-10 (2017)
Abstract Background Late-onset Pompe disease is a rare genetic neuromuscular disorder caused by lysosomal acid alpha-glucosidase (GAA) deficiency that ultimately results in mobility loss and respiratory failure. Current enzyme replacement therapy wit
Externí odkaz:
https://doaj.org/article/0f42cc539c044d06b2948b37cb169a2e
Autor:
Howard Trachtman, James R Woodworth, Frank S. Czerwiec, Krishna Padmanabhan, Leslie Johnson, Hiddo J.L. Heerspink, Youssef M K Farag, Debbie S. Gipson, Caitlin Cornwall, Xin-Ru Pan-Zhou, Liron Walsh, John F. Reilly, Katherine R. Tuttle, Gregory A Gaich
Publikováno v:
Kidney International Reports
Kidney International Reports, 6(10), 2575-2584. ELSEVIER SCIENCE INC
Kidney International Reports, 6(10), 2575-2584. ELSEVIER SCIENCE INC
Introduction A critical unmet need exists for precision therapies for chronic kidney disease. GFB-887 is a podocyte-targeting, small molecule inhibitor of transient receptor potential canonical-5 (TRPC5) designed specifically to treat patients with g
Autor:
Edward J. Gane, Jörg Täubel, Björn Pilebro, Marianna Fontana, Justin Kao, Michael Maitland, Mark Stroh, Jessica Seitzer, Jonathan Phillips, Kristy Wood, Yuanxin Xu, Carri Boiselle, Adam Amaral, Adam Boyd, Jeffrey Cehelsky, David Gustein, Odelya Pagovich, Laura Sepp-Lorenzino, Liron Walsh, David Lebwohl, Gillmore Julian
Publikováno v:
Journal of Hepatology. 77:S58-S59
Autor:
Debbie S. Gipson, Howard Trachtman, Joseph M. LaVigne, Susan F. Massengill, Hailey Desmond, Noelle E. Carlozzi, Neena Singhal, Liron Walsh, Jennifer A. Miner, Christian Lynam
Publikováno v:
Kidney Medicine
Rationale & Objective Assessment of how patients feel and function is needed for clinical care and research for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). The objective of this study was to develop a patient-reported
Autor:
Liron Walsh, Jonathan P. Troost, Jeffrey B. Kopp, Richard N. Fine, Debbie S. Gipson, Marva Moxey-Mims, Cathie Spino, Frederick J. Kaskel, Rong Wang, Jennifer J. Gassman, Aaron L. Friedman, Howard Trachtman
Publikováno v:
Am J Kidney Dis
Rationale & Objective Remission of proteinuria has been shown to be associated with lower rates of kidney disease progression among people with focal segmental glomerulosclerosis (FSGS). The goal of this study was to evaluate whether reductions in pr
Autor:
Hua Yu, Michael Laffan, Liron Walsh, Savita Rangarajan, David Perry, Glenn F. Pierce, Christian Vettermann, Wing Yen Wong, K. John Pasi, Will Lester, Bella Madan
Background Patients with hemophilia A rely on exogenous factor VIII to prevent bleeding in joints, soft tissue, and the central nervous system. Although successful gene transfer has been reported in patients with hemophilia B, the large size of the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4024b00e18bbd0f716af1b6f423e6c1d
http://hdl.handle.net/10044/1/57163
http://hdl.handle.net/10044/1/57163
Autor:
Geoffrey A. Block, David A. Bushinsky, John Cunningham, Tilman B. Drueke, Markus Ketteler, Reshma Kewalramani, Kevin J. Martin, T. Christian Mix, Sharon M. Moe, Uptal D. Patel, Justin Silver, David M. Spiegel, Lulu Sterling, Liron Walsh, Glenn M. Chertow
Publikováno v:
JAMA. 317(2)
Secondary hyperparathyroidism contributes to extraskeletal complications in chronic kidney disease.To evaluate the effect of the intravenous calcimimetic etelcalcetide on serum parathyroid hormone (PTH) concentrations in patients receiving hemodialys
Autor:
Liron Walsh, Rajani Dinavahi
Publikováno v:
Frontiers in bioscience (Elite edition). 8(1)
While has been considerable progress in the short-term outcomes following renal transplantation over the last several decades, minimal gains have been made with regards to long-term graft function and patient survival (1). The lack of long-term gains